Capital Engine Message

Sign up or sign in to view all of the available information for this offering.

Per SEC regulations, certain details can only be shown to registered members.

    Questions on Capital Raising? Give us a call (800) 806-7570 or email at invest@capitalengine.io

  • Log In
  • Signup
site logo
Capital Engine Logo
  • BROKER DEALER
  • HOW IT WORKS
  • MARKETPLACE
  • MEDICAL 40 - ALBUQUERQUE MEDICAL OFFICE

  • 5601 Office Boulevard Northeast, Albuquerque, NM, USA
  • Overview
  • Investment
  • Sponsor
  • Location
  • Financials
  • Gallery
  • Documents
 OrbVest Global Real Estate
 Investment Overview

OrbVest is pleased to present the Albuquerque Medical Office building. This well-maintained Class A medical office property is located in the northern part of the Albuquerque MSA. The property totals 50,526 SF and is approximately 85% occupied by three tenants.

OrbVest believes this is a great opportunity to acquire a medical office asset in a rapidly-growing MSA with good value-add opportunity in the US. he property, situated at 5601 Office Boulevard, Albuquerque, New Mexico, is a well-maintained Class A medical office building.

The property totals 50,526 SF with a current occupancy of roughly 85%. The property was completed in 1999 and since then substantial tenant improvement packages have been completed. The property, which sits on 4.12 acres of land, is currently occupied by three tenants, with one vacant space. The weighted average lease term (WALT) is 6.25 years.

The strategy is to hold the property for a five-year period, during which existing leases that expire will be renewed. The vacant space will be leased during the first year of ownership.

OrbVest will be the sponsor of this transaction and will contract with Plaza Property Management, to manage the property and the leasing.

Company Info

 OrbVest Global Real Estate
 Company


OrbVest will be the sponsor of this transaction. We will contract with Lincoln Harris to manage the property and the leasing.

OrbVest is a global real estate company that has a hyper-focus on acquiring stable income producing medical buildings in the USA. Investors have to date invested directly into individual buildings, which gives them a direct investment in blue chip real estate in the USA and all risk is limited to that specific building.

Investors have traditionally invested directly into the individual buildings offered by OrbVest, providing an alternative investment opportunity to investors in more than 30 countries to hold and grow their wealth in this robust asset class in the USA, with all risks limited to that specific investment building.

Investment Highlights

 OrbVest Global Real Estate
 Investment Opportunity

OrbVest is pleased to present the Albuquerque Medical Office building. This well-maintained Class A medical office property is located in the northern part of the Albuquerque MSA. The property totals 50,526 SF and is approximately 85% occupied by three tenants.

OrbVest believes this is a great opportunity to acquire a medical office asset in a rapidly-growing MSA with good value-add opportunity in the US. he property, situated at 5601 Office Boulevard, Albuquerque, New Mexico, is a well-maintained Class A medical office building.

The property totals 50,526 SF with a current occupancy of roughly 85%. The property was completed in 1999 and since then substantial tenant improvement packages have been completed. The property, which sits on 4.12 acres of land, is currently occupied by three tenants, with one vacant space. The weighted average lease term (WALT) is 6.25 years.

The strategy is to hold the property for a five-year period, during which existing leases that expire will be renewed. The vacant space will be leased during the first year of ownership.

OrbVest will be the sponsor of this transaction and will contract with Plaza Property Management, to manage the property and the leasing.

Great Location
The Albuquerque medical office building is located approximately 4.5 miles north of downtown Albuquerque, New Mexico, in a prime central position.

Medical Office Building
The property has a total of 50,526 square feet and is currently 84.56% leased with one vacant space.

Returns
Forecast quarterly dividend between 7.0% - 7.10% annualized with a targeted IRR range of 12.0% to 13.0% (before tax).

Purchase
The total acquisition cost is $11,574,683 million of which $2.07 million has been provided for tenant installation and transaction costs.

Funding
The $4.28 million equity includes an investment from OrbVest.

Holding Period
The investment period is planned for 5 years.

Financial Snapshot

  • Investment Type: Medical Office
  • Offering Type: Equity
  • Funding Goal: $4,153,730
  • Minimum Investment Amount: $5,000
  • LTV: 63
CAPITAL STACK

Total

Financial Highlights

      • Forecast quarterly dividend between 7.0% - 7.1% annualized with a targeted IRR range of 12.0 to 13.0% (before tax).
      • The total acquisition cost is $11,574,683 million of which $2.07 million has been provided for tenant installation and transaction costs.
      • The $4.28 million equity includes an investment from OrbVest.

Image Gallery

×
Hang in there...

Image Gallery

Documents

Project Title Document Title Action
MEDICAL 40 - ALBUQUERQUE MEDICAL OFFICE Subscription Agreement View

Investment Location

Instructions

Perks

Frequently Asked Questions (FAQ)

Discussion

Profile picture of
Please sign in to post a comment.

Terms

Sign up to invest Schedule a call

Investment Summary

  • Deal Type: Investment
  • Sponsor: Orbvest Ltd
  • Hold Period: 5 YR
  • Investor Yield: 12
  • Funding Goal:$4,153,730
  • Investment Type: Medical Office
  • Min. Investment: $5,000
  • Medical 40 - Albuquerque Medical Office Brochure

Contact Investor Relations



By sending, you agree to Capital Engine Terms and Conditions

  SEND REQUEST
Profile picture of
about 0 sec ago
0 Like Reply View All Discussion
Profile picture of
Profile picture of
@
0 Like · Reply
· About 0 seconds ago
View All Discussion
Profile picture of
0 Like
· About 0 seconds ago
USAReit_footer_logo

Get in Touch

  • invest@capitalengine.io
  • (800) 806-7570

Company

  • Contact Us
  • Terms
  • Privacy

Get Financing

  • How It Works
  • Raise Capital
  • Broker Dealer Services

Invest

  • Invest

Learn

  • The Engine Room (News)
  • Learning Center

Important Message: In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. Investments on Capital Engine® are speculative, illiquid, and involve a high degree of risk, including the possible loss of your entire investment.

Capital Engine® is a financial technology company, that provides scalable private capital market infrastructure and investment management solutions, for broker-dealers, investment banks, family offices, wealth managers, real estate funds and equity crowdfunding portals.


Capital Engine® is not licensed by or registered with the U.S. Securities and Exchange Commission, FINRA, or any other financial services regulator. Specifically, Capital Engine® is not a FINRA registered Broker Dealer and does not offer or sell securities, or engage in any other Broker Dealer activity. Nothing in this website constitutes an offer, distribution, solicitation, or marketing of any security. Capital Engine® is not an exchange, alternative trading system, escrow agent or transfer agent. Capital Engine® does not provide legal, accounting, tax, or regulatory advice, or hold custody of cash, virtual currency, security token or digital assets for or on behalf of any third party. 

Securities offered through Mallory Capital Group, LLC, a SEC registered broker-dealer and member FINRA/SIPC. By viewing and using CapitalEngine.io you agree to be bound by our Terms of Use and Privacy Policy.


No communication, through this website or otherwise, should be construed as a recommendation for any securities offering on or off our platform. Securities are offered pursuant to Regulation Crowdfunding of the Securities Act of 1933 ("Reg Crowdfunding Offerings"), Regulation D of the Securities Act of 1933 ("Reg D Offerings") and Regulation A of the Securities Act of 1933 ("Reg A+ Offerings"). All company listings are only appropriate for investors who are familiar with and willing to accept the high risk associated with startup investments. Securities sold are not publicly traded and are not liquid investments. Companies seeking investments through equity crowdfunding tend to be in very early stages of development with little or no operating history. Investors must be able to afford to hold their investment for an indefinite period of time, as well as the ability to lose their entire investment.

© 2018 - 2025 Capital Engine Inc. All Rights Reserved.

Confirm

Capital Engine Message

Confirm

https://capitalengine.io

Speak With Our Investor Relations Team

  • Request a Callback
  • Book a Call
Full name is required
Valid email is required
Valid phone number is required

By sending you agree to Capital Engine's Terms & Conditions